Efficacy of Dupilumab on Different Phenotypes of Adult with Moderate-to-Severe Atopic Dermatitis in Taiwan: A Real-World Study

To determine phenotype-related dupilumab response in adult patients with atopic dermatitis (AD), this multicenter, retrospective study included 111 adults with moderate-to-severe AD in Taiwan, with median age of 31.5 years (18–87) and 71 (64.0%) males. Patients received dupilumab 300 mg per two to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chin-Yi, Lai, Po-Ju, Chen, Chun-Bing, Chan, Tom C., Hui, Rosaline Chung-Yee, Huang, Yu-Huei, Tseng, Han-Chi, Lin, Shang-Hung, Lu, Chun-Wei, Lee, Hua-En, Lin, Jing-Yi, Chi, Min-Hui, Tsai, Ming-Feng, Hwang, Yih-Shiou, Wang, Chuang-Wei, Chu, Chia-Yu, Chung, Wen-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605350/
https://www.ncbi.nlm.nih.gov/pubmed/36294530
http://dx.doi.org/10.3390/jcm11206209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605350/
https://www.ncbi.nlm.nih.gov/pubmed/36294530
http://dx.doi.org/10.3390/jcm11206209

Ejemplares similares